Wellington Management Group
BIOL

Wellington Management Group’s Biolase, Inc. BIOL Stock Holding History

Wellington Management Group’s Portfolio BIOL Stock Details BIOL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-16
Closed -$487K – 2258
2014
Q3 		$487K Buy
+16
New +$452K ﹤0.01% 1990

Other funds holding BIOL

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
PCMI
Princeton Capital Management Inc Princeton, New Jersey $198M AUM 28.98% 1-Year Est. Return
TA
Teton Advisors Rye, New York $142M AUM 42.07% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Wellington Management Group's BIOL Position: Q4 2014 in Review

Wellington Management Group sold out of Biolase, Inc. (BIOL) in Q4 2014, closing a stake of 16 shares — an estimated $487K sold.

Wellington Management Group first reported a position in BIOL in Q3 2014 and held it in 1 quarter. The position peaked at $487K in Q3 2014. 36 funds tracked by Wall St. Rank hold BIOL as of Q4 2014.

  • Wellington Management Group reported no remaining Biolase, Inc. position as of Q4 2014 after selling out during the quarter.
  • Wellington Management Group sold 16 Biolase, Inc. shares in Q4 2014, an estimated $487K.
  • Wellington Management Group first reported a position in Biolase, Inc. in Q3 2014 and held it in 1 quarter.
  • Wellington Management Group's Biolase, Inc. position peaked at $487K in Q3 2014.
  • 36 funds tracked by Wall St. Rank held Biolase, Inc. as of Q4 2014.

Based on Wellington Management Group's 13F filing for Q4 2014, filed 13 Feb 2015.